Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Congress 2022

09 - 13 Sep 2022

Paris, France

ESMO-Congress-2022-1000x1000

Resources are available according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

Abstracts and ePosters are open access.
Slides and webcasts are reserved to registered Delegates (6 months) and ESMO Members.

Understanding the disease to provide better CARE for #cancer patients

Practice changing data and high quality education in more than 20 tracks covering all tumour types, therapeutic innovations, translational research, patient advocacy, public policy, and more...


Congress coverage: Expert video reports  |  Highlight videos  |  News articles 

Quick access to special sessions

Open access - Clinical Practice Guidelines session 1 (eBC, CUP, Biliary tract)

Open access - Clinical Practice Guidelines session 2 (Bladder, CNS Lymphoma, mNSCLC)

ESMO Colloquia

Satellite webcasts from our Industry partners

Hide
Filter by:

There are 2867 resources available

Preparing the Clinics and Future Prospects

Presenter: Enriqueta Felip

Session: Medscape Oncology Global - Targets of Antibody-Drug Conjugates in NSCLC: Diagnostics, Emerging Therapies, and Future Prospects

Resources:

Webcast

Q&A Session

Presenter: Egbert Smit

Session: Medscape Oncology Global - Targets of Antibody-Drug Conjugates in NSCLC: Diagnostics, Emerging Therapies, and Future Prospects

Resources:

Webcast

Q&A session

Presenter: Eric Van Cutsem

Session: Astellas Pharma Europe Ltd - Navigating the evolving landscape of locally advanced unresectable or metastatic G/GEJ adenocarcinoma

Resources:

Webcast

Interactive Multidisciplinary Team Meeting

Presenter: Margitta Retz

Session: Bristol Myers Squibb - Navigating the Integration of Immuno-Oncology Into the Perioperative Muscle-Invasive Urothelial Carcinoma Treatment Landscape

Resources:

Webcast

Concluding Remarks

Presenter: Enriqueta Felip

Session: Medscape Oncology Global - Targets of Antibody-Drug Conjugates in NSCLC: Diagnostics, Emerging Therapies, and Future Prospects

Resources:

Webcast

Meeting summary and close

Presenter: Hanneke van Laarhoven

Session: Astellas Pharma Europe Ltd - Navigating the evolving landscape of locally advanced unresectable or metastatic G/GEJ adenocarcinoma

Resources:

Webcast

Q&A

Presenter: Margitta Retz

Session: Bristol Myers Squibb - Navigating the Integration of Immuno-Oncology Into the Perioperative Muscle-Invasive Urothelial Carcinoma Treatment Landscape

Resources:

Webcast

Sarcoma

Presenter: Tom Wei-Wu Chen

Session: Congress Highlights 2

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.